Search Results 891-900 of 16075 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Lou Gehrig's Disease, or ALS, is a condition that slowly robs you of your ability to move, eat or even breathe. A related condition called frontotemporal ...
Mayo Clinic researcher Garvan C. Kane, M.D., Ph.D., studies echocardiography to improve the diagnosis and outcomes of people with cardiovascular diseases.
The purpose of this study is to assess the effectiveness and safety of pembrolizumab (MK-3475) for the treatment of women with advanced ovarian cancer who have ...
The purpose of this study is to evaluate the inhibition of lymphocyte proliferation in ECP treated MNC samples obtained from cGVHD subjects treated with the ...
The purpose of this study is to evaluate JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway ...
Mayo Clinic Laboratories.
This phase I trial identifies the best dose, possible benefits, and/or side effects of duvelisib in combination with nivolumab in treating patients with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.